A detailed history of Rnc Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rnc Capital Management LLC holds 16,470 shares of ABT stock, worth $1.96 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
16,470
Previous 16,470 -0.0%
Holding current value
$1.96 Million
Previous $1.71 Million 9.7%
% of portfolio
0.1%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $294,735 - $328,999
2,926 Added 21.6%
16,470 $1.71 Million
Q1 2024

Aug 07, 2024

SELL
$109.52 - $120.96 $117,843 - $130,152
-1,076 Reduced 7.36%
13,544 $1.54 Million
Q4 2023

Jan 17, 2024

SELL
$90.19 - $110.4 $92,264 - $112,939
-1,023 Reduced 6.54%
14,620 $1.61 Million
Q3 2023

Dec 27, 2023

SELL
$95.53 - $114.62 $61,043 - $73,242
-639 Reduced 3.92%
15,643 $1.52 Million
Q2 2023

Jul 20, 2023

BUY
$100.78 - $112.29 $41,823 - $46,600
415 Added 2.62%
16,282 $1.78 Million
Q1 2023

Apr 21, 2023

SELL
$96.86 - $114.01 $27,023 - $31,808
-279 Reduced 1.73%
15,867 $1.61 Million
Q4 2022

Jan 10, 2023

SELL
$95.06 - $111.52 $177,381 - $208,096
-1,866 Reduced 10.36%
16,146 $1.77 Million
Q3 2022

Oct 18, 2022

SELL
$96.76 - $112.03 $58,539 - $67,778
-605 Reduced 3.25%
18,012 $1.74 Million
Q2 2022

Jul 22, 2022

BUY
$102.07 - $123.37 $1.65 Million - $1.99 Million
16,163 Added 658.64%
18,617 $2.02 Million
Q1 2022

Jul 22, 2022

SELL
$114.02 - $139.04 $353,690 - $431,302
-3,102 Reduced 55.83%
2,454 $291,000
Q4 2021

Feb 04, 2022

SELL
$115.53 - $141.46 $31,424 - $38,477
-272 Reduced 4.67%
5,556 $782,000
Q2 2021

Jul 20, 2021

SELL
$105.79 - $124.53 $18,513 - $21,792
-175 Reduced 2.92%
5,828 $676,000
Q1 2021

Apr 26, 2021

SELL
$108.84 - $128.23 $661,094 - $778,869
-6,074 Reduced 50.29%
6,003 $720,000
Q4 2020

Jan 13, 2021

SELL
$105.0 - $114.42 $23,205 - $25,286
-221 Reduced 1.8%
12,077 $1.32 Million
Q3 2020

Dec 03, 2020

BUY
$91.64 - $111.29 $20,252 - $24,595
221 Added 1.83%
12,298 $1.34 Million
Q2 2020

Jul 23, 2020

SELL
$76.57 - $98.0 $81,240 - $103,978
-1,061 Reduced 8.08%
12,077 $1.1 Million
Q1 2020

Apr 22, 2020

SELL
$62.82 - $91.86 $1,130 - $1,653
-18 Reduced 0.14%
13,138 $1.04 Million
Q4 2019

Mar 09, 2020

BUY
$78.51 - $87.4 $5,652 - $6,292
72 Added 0.55%
13,156 $1.14 Million
Q3 2019

Jul 22, 2020

BUY
$81.84 - $88.74 $2,291 - $2,484
28 Added 0.21%
13,084 $1.1 Million
Q1 2019

Apr 18, 2019

SELL
$66.22 - $80.06 $10,330 - $12,489
-156 Reduced 1.18%
13,056 $1.04 Million
Q4 2018

Jan 15, 2019

SELL
$65.56 - $74.27 $65 - $74
-1 Reduced 0.01%
13,212 $956,000
Q3 2018

Oct 25, 2018

SELL
$60.81 - $73.36 $313,049 - $377,657
-5,148 Reduced 28.04%
13,213 $969,000
Q2 2018

Jul 20, 2018

SELL
$57.57 - $63.54 $102,129 - $112,719
-1,774 Reduced 8.81%
18,361 $1.12 Million
Q1 2018

Apr 11, 2018

BUY
$56.27 - $63.62 $156,318 - $176,736
2,778 Added 16.01%
20,135 $1.21 Million
Q4 2017

Jan 17, 2018

SELL
$53.68 - $57.47 $1,986 - $2,126
-37 Reduced 0.21%
17,357 $991,000
Q2 2017

Aug 22, 2017

BUY
N/A
17,394
17,394 $846,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rnc Capital Management LLC Portfolio

Follow Rnc Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.